Distinguishing between primary and secondary hyperparathyroidism is a fundamental step in diagnosing and treating parathyroid disease. Both conditions involve an overproduction of parathyroid hormone, which is the primary chemical messenger used by the body to regulate calcium levels. However, the root cause of the hormonal surge differs significantly between the two. In primary hyperparathyroidism, the issue is located within the parathyroid glands themselves, whereas in secondary hyperparathyroidism, the glands are reacting to an external health problem that is driving calcium levels down. Because the underlying mechanisms are distinct, the impact on blood calcium and the necessary clinical interventions also vary, requiring a precise medical assessment to ensure the correct management strategy is applied.
What We’ll Discuss in This Article
- The fundamental physiological definitions of primary and secondary hyperparathyroidism.
- How blood calcium levels differ between the two conditions.
- The specific role of benign tumours versus systemic illnesses like kidney disease.
- The impact of vitamin D deficiency on parathyroid hormone production.
- Diagnostic testing and how doctors differentiate between the types.
- Overview of treatment approaches for both primary and secondary forms.
Defining Primary Hyperparathyroidism
Primary hyperparathyroidism occurs when one or more of the parathyroid glands becomes overactive independently of the body’s needs. In this state, the gland loses its ability to sense when there is already enough calcium in the blood and continues to secrete parathyroid hormone (PTH) excessively. The most common cause, accounting for approximately 80 percent of cases, is a single benign (non cancerous) growth known as an adenoma. Less frequently, it may be caused by hyperplasia, where all four glands enlarge, or in very rare instances, a parathyroid carcinoma.
The hallmark of primary hyperparathyroidism is the presence of high blood calcium levels (hypercalcaemia) alongside inappropriately high levels of PTH. Because the gland is acting autonomously, it ignores the natural feedback loop that should shut down hormone production when calcium is elevated. This leads to the classic symptoms of “moans, stones, and groans,” as the body is forced to pull calcium from the bones and keep it in the bloodstream. Clinical guidance from the National Institute for Health and Care Excellence emphasizes that surgery to remove the overactive gland is the definitive treatment for primary hyperparathyroidism when symptoms or high calcium levels are present.
Defining Secondary Hyperparathyroidism
Secondary hyperparathyroidism is not a disease of the parathyroid glands themselves, but rather a normal physiological response to an underlying condition that is causing low calcium levels. In this scenario, the glands are healthy and are simply doing their job by producing more PTH to try and bring blood calcium back to a safe range. The glands become enlarged over time because they are working constantly to compensate for the deficiency elsewhere in the body.
The two most common triggers for secondary hyperparathyroidism are chronic kidney disease and severe vitamin D deficiency. In kidney disease, the kidneys lose the ability to activate vitamin D and excrete phosphate effectively, both of which lead to falling calcium levels. In vitamin D deficiency, the intestines cannot absorb enough calcium from food. In both cases, the parathyroid glands sense the drop and ramp up PTH production. Unlike the primary form, blood calcium in secondary hyperparathyroidism is usually low or at the low end of the normal range, while PTH is high.
Comparison of Calcium and Phosphate Levels
One of the most effective ways for clinicians to tell the difference between these two conditions is by looking at the relationship between calcium, phosphate, and PTH in a blood sample. Because the glands behave differently in each condition, the chemical profile in the blood is often distinct.
| Feature | Primary Hyperparathyroidism | Secondary Hyperparathyroidism |
| Parathyroid Hormone (PTH) | High | High |
| Blood Calcium | High (Hypercalcaemia) | Low or Normal (Hypocalcaemia) |
| Phosphate | Low or Normal | High (if caused by kidney disease) |
| Primary Source of Issue | The parathyroid gland itself | Kidney failure or Vitamin D deficiency |
| Common Treatment | Surgery (Parathyroidectomy) | Treating the underlying cause (e.g. Vitamin D) |
In primary hyperparathyroidism, the high PTH “pushes” the calcium up. In secondary hyperparathyroidism, the low calcium “pulls” the PTH up. This distinction is vital because treating a patient with secondary hyperparathyroidism with surgery would not solve the problem, as the remaining glands would simply continue to overproduce hormone to compensate for the underlying deficiency.
The Role of Chronic Kidney Disease
Chronic kidney disease is the leading cause of secondary hyperparathyroidism in the UK. The kidneys are essential for mineral balance because they convert vitamin D into its active form and filter out excess phosphate. As kidney function declines, phosphate builds up in the blood and active vitamin D levels drop. Both of these factors cause calcium levels to plummet. The parathyroid glands respond by growing larger (hyperplasia) and producing massive amounts of PTH to try and extract calcium from the bones to compensate.
If this condition persists for many years, it can lead to a third stage called tertiary hyperparathyroidism. This occurs when the parathyroid glands, after being overstimulated for a long time, lose their ability to turn off even if the kidney problem is fixed (for example, after a kidney transplant). In tertiary hyperparathyroidism, both PTH and calcium become high, similar to the primary form, but it occurs specifically in the context of long term kidney issues. NHS England provides specialised pathways for renal patients to monitor and manage these mineral and bone disorders as part of their long term care.
Diagnostic Pathways and Testing
To differentiate between primary and secondary hyperparathyroidism, doctors follow a structured diagnostic pathway. The first step is a simple blood test to check the “calcium-PTH axis.” If calcium is high and PTH is also high (or even in the high-normal range), primary hyperparathyroidism is the likely diagnosis. If calcium is low and PTH is high, the doctor will look for a secondary cause, starting with vitamin D levels and kidney function tests (creatinine and GFR).
In cases where primary hyperparathyroidism is suspected, imaging tests such as a Sestamibi scan or an ultrasound of the neck may be used to locate the specific gland that has the adenoma. These scans are not typically used for secondary hyperparathyroidism because the issue is not a single growth but a systemic reaction. Determining the correct type is essential because the management for vitamin D deficiency (supplements) is vastly different from the management of an adenoma (surgery).
Treatment and Management Strategies
The treatment goals for primary and secondary hyperparathyroidism are fundamentally different. For primary hyperparathyroidism, the goal is to remove the autonomous source of the hormone. Surgery is highly successful, with over 95 percent of patients being cured by the removal of the single overactive gland. Once the gland is removed, calcium levels usually return to normal within hours or days.
For secondary hyperparathyroidism, the goal is to fix the underlying trigger. If the cause is vitamin D deficiency, high-dose vitamin D supplements are prescribed to help the gut absorb more calcium. If the cause is kidney disease, management involves a combination of phosphate binders (medications taken with food), active vitamin D analogues, and dietary changes to reduce phosphate intake. Surgery is only considered in secondary or tertiary cases if medical management fails to control the PTH levels and the patient begins to suffer from severe bone pain or other complications.
Conclusion
The key difference between primary and secondary hyperparathyroidism lies in whether the gland is the cause of the problem or a responder to a problem elsewhere. Primary disease leads to high blood calcium and usually requires surgery, while secondary disease is a reaction to low calcium and requires treating the underlying deficiency or illness. Accurate diagnosis is critical for restoring mineral balance and protecting bone health. If you experience severe, sudden, or worsening symptoms, call 999 immediately.
Can you have both primary and secondary hyperparathyroidism?
It is technically possible but rare. Usually, a patient has one or the other. However, a person with secondary disease due to vitamin D deficiency can eventually develop an autonomous gland (tertiary disease).
Is surgery the only way to treat primary hyperparathyroidism?
Surgery is the only cure. In some cases, if the patient is elderly or surgery is too risky, medications called calcimimetics may be used to “trick” the gland into producing less hormone.
How does vitamin D affect the parathyroid?
Vitamin D helps the body absorb calcium. If you don’t have enough, your calcium levels drop, which forces your parathyroid glands to work harder and produce more hormone
Is primary hyperparathyroidism hereditary?
Most cases are sporadic (happen by chance), but in a small number of cases, it can be part of a hereditary syndrome like Multiple Endocrine Neoplasia (MEN
Why is phosphate important in kidney-related parathyroid disease?
High phosphate levels directly stimulate the parathyroid glands to produce more hormone and also bind to calcium, making blood calcium levels drop even further.
What are the symptoms of secondary hyperparathyroidism?
The symptoms are often those of the underlying cause, such as bone pain, joint pain, or the symptoms of kidney failure like fatigue and itchy skin.
Can primary hyperparathyroidism be prevented?
There is currently no known way to prevent the benign adenomas that cause primary hyperparathyroidism, but secondary disease can often be prevented by maintaining adequate vitamin D levels.
Authority Snapshot (E-E-A-T)
The Medical Content Team at MyPatientAdvice provides evidence-based education strictly aligned with UK clinical standards. This article has been reviewed by Dr. Stefan Petrov, a UK-trained physician with extensive experience in internal medicine and emergency diagnostics. All recommendations and clinical definitions are based on established guidelines from the NHS and NICE.
